Miss Bethany A Haskins, PA-C | |
1322 Eisenhower Blvd, Johnstown, PA 15904-3307 | |
(814) 536-8969 | |
(814) 536-7180 |
Full Name | Miss Bethany A Haskins |
---|---|
Gender | Female |
Speciality | Physician Assistant - Medical |
Location | 1322 Eisenhower Blvd, Johnstown, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609937507 | NPI | - | NPPES |
1007708200001 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MA052224 (Pennsylvania) | Secondary |
363AM0700X | Physician Assistant - Medical | MA052224 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miss Bethany A Haskins, PA-C 1322 Eisenhower Blvd, Johnstown, PA 15904-3307 Ph: (814) 536-8969 | Miss Bethany A Haskins, PA-C 1322 Eisenhower Blvd, Johnstown, PA 15904-3307 Ph: (814) 536-8969 |
News Archive
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Over the last decade the popularity of soaps and cleaning products claiming to have anti-bacterial properties has mushroomed as consumers are persuaded, by clever marketing, that they offer a defense against household illnesses.
Spectranetics Corporation today announced that the Japanese Ministry of Health, Labor and Welfare granted approval for the LLD lead locking device, which is used for the removal of pacemaker and defibrillator cardiac leads.
Ophthotech Corporation announced today that scientists at the University of Pennsylvania and University of Florida published proof-of-concept study results on an adeno-associated virus gene therapy product candidate for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa licensed by Ophthotech.
› Verified 8 days ago